Is a complete TSXV/CNVI research report available?

No complete published report is available for tsxv/CNVI (TSXV/CNVI) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

TSXV/CNVI (TSXV/CNVI)

TSX Venture Exchange: TSXV/CNVI · CAD

CA$0.20

+0.02 (+8.1%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-29 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first TSXV/CNVI analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	19.1M
Revenue (ttm)	778K
Net income (ttm)	-17.8M
EPS (ttm)	-CA$0.22
Shares out	103.5M
Volume	500

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 778K
Net income (ttm): -17.8M
EPS (ttm): -CA$0.22
Market cap: 19.1M

All TSXV/CNVI indicators

Market & fundamental data

Available fields

148

Groups with data

Currency

CAD

Showing 148 of 148 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Enterprise value	CAD 32.9M
Exchange	TSX Venture Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Medical Devices
Last refreshed	2026-07-29
Market cap	CAD 19.1M
Price	CAD 0.2
Price currency	CAD
Sector	Healthcare
Sic	3845
Symbol	tsxv/CNVI
Website	https://www.conavi.com/novasight/

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-93.23%
EV/Sales	42.25x
FCF yield	-123.97%
P/B ratio	-1.37x
P/S ratio	24.61x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-580.21%
EBITDA Margin	-490.75%
Gross margin	95.63%
Gross Profit	CAD 744,000
Gross Profit Growth	-89.68%
Gross Profit Growth Q	-10.34%
Net Income	CAD -17.8M
Pretax Margin	-2,294.22%
ROA	-115
ROCE	-65.04

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-58.36%
Revenue Growth	-91.87x
Revenue Growth Q	124.14x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.07
Assets	CAD 14.3M
Cash	CAD 4.5M
Current Assets	CAD 10.3M
Current Liabilities	CAD 7.4M
Debt	CAD 18.2M
Debt FCF	CAD -0.77
Equity	CAD -14M
Interest Coverage	-4.81
Liabilities	CAD 28.3M
Long Term Assets	CAD 4M
Long Term Liabilities	CAD 20.9M
Net Cash	CAD -13.7M
Net Cash By Market Cap	CAD -71.67
Tangible Book Value	CAD -16.2M
Tangible Book Value Per Share	CAD -0.16

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.4
Inventory Turnover	0.32
Net Working Capital	CAD -246,000
Quick ratio	0.72
Working Capital	CAD 2.9M
Working Capital Turnover	CAD -0.33

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-233.3%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-58.33%
200-day SMA	0.41
50-day SMA	0.24
50-day SMA vs 200-day SMA	50under200
All Time High	1.52
All Time High Change	-86.84%
All Time High Date	2024-10-30
All Time Low	0.15
All Time Low Change	33.33%
All Time Low Date	2026-07-23
ATR	0.02
Beta1y	-0.13
Beta2y	-0.06
Ch YTD	-56.04
High	0.21
High52	0.7
High52 Date	2025-10-07
High52ch	-71.43%
Low	0.17
Low52	0.15
Low52 Date	2026-07-24
Low52ch	33.33%
Ma50ch	-16.39%
Price vs 200-day SMA	-51.54%
RSI	44.58
RSI Monthly	24.21
RSI Weekly	31.52
Sharpe ratio	-0.74x
Sortino ratio	-0.95
Total Return	-233.3%
Tr YTD	-56.04
Tr1m	-18.37%
Tr1w	-9.09%
Tr3m	-50%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -19.4M
Operating margin	-2,498.2

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	69,443,311%
Net Borrowing	-1,708,000
Shares Insiders	0.42%
Shares Institutions	0%
Shares Out	103,491,756
Shares Qo Q	30.15%
Shares Yo Y	233.3%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD -24.7M
Adjusted OCF	-24,610,000
Average Volume	69,828.95x
Bv Per Share	-0.14
CAPEX	CAD -52,000
Ch1m	-18.37
Ch1w	-9.09
Ch1y	-58.33
Ch3m	-50
Ch6m	-54.55
Change	8.11%
Change From Open	-4.76
Close	0.19
Days Gap	13.51
Depreciation Amortization	424,000
Dollar Volume	100
Earnings Date	2026-08-28
EBIT	CAD -4.5M
EBITDA	CAD -3.8M
EPS	CAD -0.22
F Score	3
FCF	CAD -23.7M
FCF EV Yield	-72.22x
FCF Per Share	CAD -0.23
Financing CF	27,500,000
Fiscal Year End	September
Investing CF	-359,000
Is Primary Listing	1
Last Earnings Date	2026-02-27
Last Report Date	2026-03-31
Last Split Date	2024-10-16
Last Split Type	Reverse
Ma150	0.35
Ma150ch	-43.39%
Ma20	0.21
Ma20ch	-6.24%
Net CF	3,457,000
Next Earnings Date	2026-08-28
Open	0.21
Position In Range	75
Ppne	1,741,000
Price Date	2026-07-28
Relative Volume	0.01x
Revenue	778,000x
SBC By Revenue	119.02x
Share Based Comp	926,000
Tr6m	-54.55%
Volume	500
Z Score	-20.45

TSXV/CNVI (TSXV/CNVI)

Coverage state: Market snapshot only — no published research

Generate the first TSXV/CNVI analysis

Price

Financial snapshot

Fair-value bridge

Latest news · TSXV/CNVI

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSXV/CNVI indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on TSXV/CNVI

Frequently asked questions